Other Information
−Removed: Certificate of Designation designating the Series B Cumulative Preferred Stock of the Company (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K of the Company filed with the SEC on May 5, 2021).
−Removed: Indenture, dated as of April 20, 2021, by and between the Company and U.S.
−Removed: Bank National Association, as Trustee (incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company filed with the SEC on April 20, 2021).
−Removed: First Supplemental Indenture, dated as of April 20, 2021, by and between the Company and U.S.
−Removed: Bank National Association, as Trustee (incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K of the Company filed with the SEC on April 20, 2021).
−Removed: Form of 8.625% Senior Note due 2026 (included in Exhibit 4.2).
−Removed: Securities Purchase Agreement, dated as of May 5, 2021, by and between the Company and B.
−Removed: Riley Securities, Inc.
−Removed: (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the SEC on May 5, 2021).
+Added: January 2018, John Erick and Deborah Ferrell, successors-in-interest and heirs of Jade Erick, (collectively “Erick”) filed
+Added: a lawsuit in the San Diego County Superior Court against Kim Kelly, ND, MPH asserting claims related to the death of Jade Erick.
+Added: 2018, Erick filed an amendment to the lawsuit, naming us as a co-defendant.
+Added: In September 2018, co-defendant Dr.
+Added: Kelly filed a cross-complaint
+Added: against the Company and various entities affiliated with Spectrum Laboratory Products, Inc., Spectrum Chemical Manufacturing Corp.
+Added: Spectrum Pharmacy Products, Inc.
+Added: (collectively “Spectrum”).
+Added: The cross-complaint sought indemnity and contribution from us
+Added: and Spectrum.
+Added: In November 2021, the lawsuit involving us was resolved.
+Added: There was no impact to our consolidated financial position and
+Added: results of operations as a result of the resolution of the case.
License and Supply Agreement, dated as of July 25, 2021, by and between the Company and Sintetica, S.A.
−Removed: First Amendment to the Harrow Health, Inc.
−Removed: 2017 Incentive Stock and Awards Plan (incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed with the SEC on April 23, 2021).
+Added: (incorporated herein by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q of the Company filed with the SEC on August 10, 2021).
+Added: Loan and Security Agreement, dated September 1, 2021, by and between the Company and Melt Pharmaceuticals, Inc.
+Added: (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the SEC on September 2, 2021).
+Added: Basic Sale and Purchase Agreement, dated as of August 18, 2021, by and between the Company and Wakamoto Pharmaceutical Co., Ltd.
+Added: License Agreement, dated as of August 18, 2021, by and between the Company and Wakamoto Pharmaceutical Co., Ltd.
Certification of Mark L.
13 unchanged sentences
XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, has been formatted in Inline
+Added: cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, has been formatted in
of this exhibit have been omitted in compliance with Item 601 of Regulation S-K.
1 unchanged sentence
the undersigned, thereunto duly authorized.
−Removed: Harrow Health, Inc.
−Removed: August 10, 2021
+Added: November 9, 2021
Executive Officer and Director
Executive Officer)
−Removed: Financial Officer
−Removed: Financial and Accounting Officer)
+Added: Financial Officer (Principal Financial and Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.